Article
Microbial fuel cell-based diagnostic platform to reveal antibacterial effect of beta-lactam antibiotics.
Enzyme and microbial technology - 1 Jun 2015
Schneider György, Czeller Miklós, Rostás Viktor, Kovács Tamás
Abstract excerpt
Beta-lactam antibiotics comprise the largest group of antibacterial agents. Due to their bactericidal properties and limited toxicity to humans they are preferred in antimicrobial therapy. In most cases, therapy is empiric since susceptibility testing in diagnostic laboratories takes a relatively long time. This paper presents a novel platform that is based on the microbial fuel cell (MFC) technology and focuses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
